Etienne A, Hecquet F, Soulard C, Spinnewyn B, Clostre F, Braquet P
Agents Actions. 1986 Jan;17(3-4):368-70. doi: 10.1007/BF01982649.
The effects of BN 52021, a new specific paf-acether receptor antagonist and the total Ginkgo Biloba extract (GBE 761) from which this product was isolated, were studied in the rat on paf-acether-induced permeability and cell number changes and on endotoxin-induced lethality. Their activities were compared to those of cyclooxygenase, 5-lipoxygenase and phospholipase A2 inhibitors. BN 52021 given s.c. or orally exerted a dose-related inhibition of paf-acether deleterious effects as well as of endotoxin lethality whereas the other drugs tested were poorly effective. These results strongly suggest paf-acether involvement in endotoxic and septic shock.
研究了新型特异性血小板活化因子(PAF)受体拮抗剂BN 52021以及从中分离出该产品的银杏叶总提取物(GBE 761)对大鼠PAF诱导的通透性和细胞数量变化以及内毒素诱导的致死率的影响。将它们的活性与环氧化酶、5-脂氧合酶和磷脂酶A2抑制剂的活性进行了比较。皮下或口服给予BN 52021对PAF的有害作用以及内毒素致死率具有剂量相关的抑制作用,而所测试的其他药物效果不佳。这些结果有力地表明PAF参与了内毒素性和败血性休克。